Maas C, de Maat S
Front Cardiovasc Med. 2021; 8:648349.
PMID: 33869308
PMC: 8044344.
DOI: 10.3389/fcvm.2021.648349.
Sanrattana W, Maas C, de Maat S
Front Med (Lausanne). 2019; 6:25.
PMID: 30809526
PMC: 6379291.
DOI: 10.3389/fmed.2019.00025.
Jaiprakash M, Kumar H, Chopra G, Mishra D
Med J Armed Forces India. 2016; 62(2):141-5.
PMID: 27406747
PMC: 4921981.
DOI: 10.1016/S0377-1237(06)80057-2.
Jacobson R, Mignemi N, Rose K, ORear L, Sarilla S, Hamm H
Thromb Res. 2014; 134(6):1350-7.
PMID: 25307422
PMC: 4337957.
DOI: 10.1016/j.thromres.2014.09.038.
Wattanakit K, Cushman M
Curr Opin Pulm Med. 2009; 15(5):408-12.
PMID: 19561505
PMC: 2811494.
DOI: 10.1097/MCP.0b013e32832ee371.
DVT prophylaxis in total hip replacement.
DeLoughery T
J Gen Intern Med. 1993; 8(11):641-2.
PMID: 8289108
DOI: 10.1007/BF02599727.
Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms.
Rosenbaum T, Rammos S, Kniemeyer H, Gobel U
Eur J Pediatr. 1993; 152(12):978-80.
PMID: 8131815
DOI: 10.1007/BF01957219.
Acquired antithrombin III deficiency and systemic lupus erythematosus.
Jarrett M, Grayzel A, Barland P, Sussman I
Ann Rheum Dis. 1981; 40(2):211.
PMID: 7224694
PMC: 1000708.
DOI: 10.1136/ard.40.2.211-a.
Hypercoagulability in the Nephrotic syndrome.
Andrassy K, Ritz E, Bommer J
Klin Wochenschr. 1980; 58(19):1029-36.
PMID: 7005524
DOI: 10.1007/BF01476873.
Intracranial bleeding during therapy with L-asparaginase in childhood acute lymphocytic leukemia.
Urban C, Sager W
Eur J Pediatr. 1981; 137(3):323-7.
PMID: 6947890
DOI: 10.1007/BF00443266.
Deficiency of protein C in congenital thrombotic disease.
Griffin J, Evatt B, ZIMMERMAN T, Kleiss A, Wideman C
J Clin Invest. 1981; 68(5):1370-3.
PMID: 6895379
PMC: 370934.
DOI: 10.1172/jci110385.
Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
Girolami A, Fabris F, Cappellato G, Sainati L, Boeri G
Blut. 1983; 47(2):93-103.
PMID: 6871478
DOI: 10.1007/BF02482643.
Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.
Jarrett M, Green D, Tsao C
J Clin Pathol. 1983; 36(3):357-60.
PMID: 6826782
PMC: 498214.
DOI: 10.1136/jcp.36.3.357.
Recurring thrombo-embolic accidents caused by family-related deficiency of the fibrinolysis system.
Alexandre P, LARCAN A, Briquel M
Blut. 1980; 41(6):437-44.
PMID: 6778541
DOI: 10.1007/BF01007768.
[Protein C deficiency--a risk factor for venous thrombosis].
Klingemann H, Broekmans A, Bertina R, Egbring R, Loeliger E
Klin Wochenschr. 1984; 62(20):975-8.
PMID: 6548780
DOI: 10.1007/BF01728427.
Familial venous thrombosis.
WINTER J, Douglas A
Postgrad Med J. 1983; 59(697):677-89.
PMID: 6359104
PMC: 2417670.
DOI: 10.1136/pgmj.59.697.677.
Natural anticoagulant mechanisms.
Rosenberg R, Rosenberg J
J Clin Invest. 1984; 74(1):1-6.
PMID: 6330171
PMC: 425178.
DOI: 10.1172/JCI111389.
Platelet and coagulation factors in proliferative diabetic retinopathy.
Borsey D, Prowse C, Gray R, Dawes J, JAMES K, Elton R
J Clin Pathol. 1984; 37(6):659-64.
PMID: 6202721
PMC: 498841.
DOI: 10.1136/jcp.37.6.659.
Intersubject variability in the anticoagulant response to heparin in vitro.
Bjornsson T, Wolfram K
Eur J Clin Pharmacol. 1982; 21(6):491-7.
PMID: 6176454
DOI: 10.1007/BF00542044.
Genetic mapping of the structural gene for antithrombin III to human chromosome 1.
Kao F, Morse H, Law M, Lidsky A, Chandra T, Woo S
Hum Genet. 1984; 67(1):34-6.
PMID: 6086493
DOI: 10.1007/BF00270555.
